Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 studyJonathan P. Piccini, Veronika Eder, Manesh R. Patel et al.|The Lancet|2022Cited by 310
Management of patients with an electrical storm or clustered ventricular arrhythmias: a clinical consensus statement of the European Heart Rhythm Association of the ESC—endorsed by the Asia-Pacific Heart Rhythm Society, Heart Rhythm Society, and Latin-American Heart Rhythm SocietyRadosław Lenarczyk, Jacob Atié, Arthur A.M. Wilde et al.|EP Europace|2024Cited by 76
EHRA consensus on prevention and management of interference due to medical procedures in patients with cardiac implantable electronic devicesMarkus Stühlinger, Takashi Nitta, Jens Cosedis Nielsen et al.|EP Europace|2022Cited by 55